Literature DB >> 29452643

Combinatorial CRISPR-Cas9 Metabolic Screens Reveal Critical Redox Control Points Dependent on the KEAP1-NRF2 Regulatory Axis.

Dongxin Zhao1, Mehmet G Badur1, Jens Luebeck2, Jose H Magaña1, Amanda Birmingham3, Roman Sasik3, Christopher S Ahn1, Trey Ideker4, Christian M Metallo5, Prashant Mali6.   

Abstract

The metabolic pathways fueling tumor growth have been well characterized, but the specific impact of transforming events on network topology and enzyme essentiality remains poorly understood. To this end, we performed combinatorial CRISPR-Cas9 screens on a set of 51 carbohydrate metabolism genes that represent glycolysis and the pentose phosphate pathway (PPP). This high-throughput methodology enabled systems-level interrogation of metabolic gene dispensability, interactions, and compensation across multiple cell types. The metabolic impact of specific combinatorial knockouts was validated using 13C and 2H isotope tracing, and these assays together revealed key nodes controlling redox homeostasis along the KEAP-NRF2 signaling axis. Specifically, targeting KEAP1 in combination with oxidative PPP genes mitigated the deleterious effects of these knockouts on growth rates. These results demonstrate how our integrated framework, combining genetic, transcriptomic, and flux measurements, can improve elucidation of metabolic network alterations and guide precision targeting of metabolic vulnerabilities based on tumor genetics.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  KEAP1; NADPH; NRF2; combinatorial CRISPR screening; genetic interactions; glycolysis; metabolic enzyme compensation; metabolic enzyme essentiality; metabolic flux analysis; redox metabolism

Mesh:

Substances:

Year:  2018        PMID: 29452643      PMCID: PMC5819357          DOI: 10.1016/j.molcel.2018.01.017

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  44 in total

1.  INCA: a computational platform for isotopically non-stationary metabolic flux analysis.

Authors:  Jamey D Young
Journal:  Bioinformatics       Date:  2014-01-11       Impact factor: 6.937

2.  Acute Activation of Oxidative Pentose Phosphate Pathway as First-Line Response to Oxidative Stress in Human Skin Cells.

Authors:  Andreas Kuehne; Hila Emmert; Joern Soehle; Marc Winnefeld; Frank Fischer; Horst Wenck; Stefan Gallinat; Lara Terstegen; Ralph Lucius; Janosch Hildebrand; Nicola Zamboni
Journal:  Mol Cell       Date:  2015-07-16       Impact factor: 17.970

3.  The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth.

Authors:  Heather R Christofk; Matthew G Vander Heiden; Marian H Harris; Arvind Ramanathan; Robert E Gerszten; Ru Wei; Mark D Fleming; Stuart L Schreiber; Lewis C Cantley
Journal:  Nature       Date:  2008-03-13       Impact factor: 49.962

4.  Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer.

Authors:  Qi Wang; Prashanth T Bhaskar; Krushna C Patra; Luke Miller; Zebin Wang; Will Wheaton; Navdeep Chandel; Markku Laakso; William J Muller; Eric L Allen; Abhishek K Jha; Gromoslaw A Smolen; Michelle F Clasquin; Brooks Robey; Nissim Hay
Journal:  Cancer Cell       Date:  2013-08-01       Impact factor: 31.743

5.  BioGRID: a general repository for interaction datasets.

Authors:  Chris Stark; Bobby-Joe Breitkreutz; Teresa Reguly; Lorrie Boucher; Ashton Breitkreutz; Mike Tyers
Journal:  Nucleic Acids Res       Date:  2006-01-01       Impact factor: 16.971

6.  Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer.

Authors:  Anju Singh; Vikas Misra; Rajesh K Thimmulappa; Hannah Lee; Stephen Ames; Mohammad O Hoque; James G Herman; Stephen B Baylin; David Sidransky; Edward Gabrielson; Malcolm V Brock; Shyam Biswal
Journal:  PLoS Med       Date:  2006-10       Impact factor: 11.069

7.  Passenger deletions generate therapeutic vulnerabilities in cancer.

Authors:  Florian L Muller; Simona Colla; Elisa Aquilanti; Veronica E Manzo; Giannicola Genovese; Jaclyn Lee; Daniel Eisenson; Rujuta Narurkar; Pingna Deng; Luigi Nezi; Michelle A Lee; Baoli Hu; Jian Hu; Ergun Sahin; Derrick Ong; Eliot Fletcher-Sananikone; Dennis Ho; Lawrence Kwong; Cameron Brennan; Y Alan Wang; Lynda Chin; Ronald A DePinho
Journal:  Nature       Date:  2012-08-16       Impact factor: 49.962

8.  Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9.

Authors:  John G Doench; Nicolo Fusi; Meagan Sullender; Mudra Hegde; Emma W Vaimberg; Jennifer Listgarten; Katherine F Donovan; Ian Smith; Zuzana Tothova; Craig Wilen; Robert Orchard; Herbert W Virgin; David E Root
Journal:  Nat Biotechnol       Date:  2016-01-18       Impact factor: 54.908

9.  Correction: KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancer.

Authors:  Elsa Beyer Krall; Belinda Wang; Diana M Munoz; Nina Ilic; Srivatsan Raghavan; Matthew J Niederst; Kristine Yu; David A Ruddy; Andrew J Aguirre; Jong Wook Kim; Amanda J Redig; Justin F Gainor; Juliet A Williams; John M Asara; John G Doench; Pasi A Janne; Alice T Shaw; Robert E McDonald Iii; Jeffrey A Engelman; Frank Stegmeier; Michael R Schlabach; William C Hahn
Journal:  Elife       Date:  2017-10-31       Impact factor: 8.140

10.  Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis.

Authors:  Rodrigo Romero; Volkan I Sayin; Shawn M Davidson; Matthew R Bauer; Simranjit X Singh; Sarah E LeBoeuf; Triantafyllia R Karakousi; Donald C Ellis; Arjun Bhutkar; Francisco J Sánchez-Rivera; Lakshmipriya Subbaraj; Britney Martinez; Roderick T Bronson; Justin R Prigge; Edward E Schmidt; Craig J Thomas; Chandra Goparaju; Angela Davies; Igor Dolgalev; Adriana Heguy; Viola Allaj; John T Poirier; Andre L Moreira; Charles M Rudin; Harvey I Pass; Matthew G Vander Heiden; Tyler Jacks; Thales Papagiannakopoulos
Journal:  Nat Med       Date:  2017-10-02       Impact factor: 53.440

View more
  31 in total

Review 1.  Genomics-guided pre-clinical development of cancer therapies.

Authors:  Hayley E Francies; Ultan McDermott; Mathew J Garnett
Journal:  Nat Cancer       Date:  2020-05-22

2.  Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.

Authors:  Takahiro Ito; Michael J Young; Ruitong Li; Sidharth Jain; Andreas Wernitznig; John M Krill-Burger; Christopher T Lemke; Davide Monducci; Diego J Rodriguez; Liang Chang; Sanjukta Dutta; Debjani Pal; Brenton R Paolella; Michael V Rothberg; David E Root; Cory M Johannessen; Laxmi Parida; Gad Getz; Francisca Vazquez; John G Doench; Mahdi Zamanighomi; William R Sellers
Journal:  Nat Genet       Date:  2021-12-02       Impact factor: 38.330

Review 3.  Tumor immunology CRISPR screening: present, past, and future.

Authors:  Matthew B Dong; Kaiyuan Tang; Xiaoyu Zhou; Jingjia J Zhou; Sidi Chen
Journal:  Trends Cancer       Date:  2021-12-15

4.  SynLethDB 2.0: a web-based knowledge graph database on synthetic lethality for novel anticancer drug discovery.

Authors:  Jie Wang; Min Wu; Xuhui Huang; Li Wang; Sophia Zhang; Hui Liu; Jie Zheng
Journal:  Database (Oxford)       Date:  2022-05-13       Impact factor: 4.462

5.  Genetic interaction mapping and exon-resolution functional genomics with a hybrid Cas9-Cas12a platform.

Authors:  Thomas Gonatopoulos-Pournatzis; Michael Aregger; Kevin R Brown; Shaghayegh Farhangmehr; Ulrich Braunschweig; Henry N Ward; Kevin C H Ha; Alexander Weiss; Maximilian Billmann; Tanja Durbic; Chad L Myers; Benjamin J Blencowe; Jason Moffat
Journal:  Nat Biotechnol       Date:  2020-03-16       Impact factor: 54.908

Review 6.  Synthetic Lethal Networks for Precision Oncology: Promises and Pitfalls.

Authors:  John Paul Shen; Trey Ideker
Journal:  J Mol Biol       Date:  2018-06-20       Impact factor: 5.469

Review 7.  In Vivo Imaging with Genetically Encoded Redox Biosensors.

Authors:  Alexander I Kostyuk; Anastasiya S Panova; Aleksandra D Kokova; Daria A Kotova; Dmitry I Maltsev; Oleg V Podgorny; Vsevolod V Belousov; Dmitry S Bilan
Journal:  Int J Mol Sci       Date:  2020-10-31       Impact factor: 5.923

8.  Niche-Selective Inhibition of Pathogenic Th17 Cells by Targeting Metabolic Redundancy.

Authors:  Lin Wu; Kate E R Hollinshead; Yuhan Hao; Christy Au; Lina Kroehling; Charles Ng; Woan-Yu Lin; Dayi Li; Hernandez Moura Silva; Jong Shin; Juan J Lafaille; Richard Possemato; Michael E Pacold; Thales Papagiannakopoulos; Alec C Kimmelman; Rahul Satija; Dan R Littman
Journal:  Cell       Date:  2020-07-01       Impact factor: 41.582

Review 9.  CRISPR screens in plants: approaches, guidelines, and future prospects.

Authors:  Christophe Gaillochet; Ward Develtere; Thomas B Jacobs
Journal:  Plant Cell       Date:  2021-05-31       Impact factor: 12.085

Review 10.  A census of pathway maps in cancer systems biology.

Authors:  Brent M Kuenzi; Trey Ideker
Journal:  Nat Rev Cancer       Date:  2020-02-17       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.